Literature DB >> 21496703

Atypical Spitzoid melanocytic tumors: a morphological, mutational, and FISH analysis.

Daniela Massi1, Anna Maria Cesinaro, Carlo Tomasini, Milena Paglierani, Stefania Bettelli, Luigino Dal Maso, Lisa Simi, Francesca Salvianti, Pamela Pinzani, Claudio Orlando, Vincenzo De Giorgi, Silvana Lukic, Antonio Maiorana, Marco Santucci, Vincenzo Canzonieri.   

Abstract

BACKGROUND: Identification of the clinical behavior of atypical Spitzoid tumors with conflicting histopathologic features remains controversial.
OBJECTIVE: We sought to assess whether molecular findings may be helpful in the diagnostic and prognostic assessment of atypical Spitzoid tumors.
METHODS: A total of 38 controversial, atypical Spitzoid lesions (≥ 1 mm in thickness) were analyzed for clinicopathological features, chromosomal alterations by fluorescence in situ hybridization (FISH) analysis (RREB1/MYB/CCND1/CEP6), BRAF(V600E) mutation by allele-specific real-time polymerase chain reaction confirmed by sequencing, and H-RAS gene mutation by direct sequencing.
RESULTS: Atypical Spitzoid lesions developed in 21 female and 17 male patients (mean age 22 years). Nine patients underwent sentinel lymph node biopsy and a sentinel lymph node micrometastasis was detected in 4 of these 9 cases. Four additional patients, who did not receive a sentinel lymph node biopsy, experienced bulky lymph node metastases and one experienced visceral metastases and death. Lesions from patients with lymph node involvement showed more deep mitoses (P < .01), less inflammation (P = .05), and more plasma cells (P = .04). FISH analysis demonstrated the presence of chromosomal alterations in 6 of 25 cases. Correlation with follow-up data showed that the only case with fatal outcome showed multiple chromosomal alterations by FISH analysis. BRAF(V600E) mutation was detected in 12 of 16 cases (75%) and H-RAS mutation on exon 3 was found in 3 of 11 cases (27%). LIMITATIONS: Our results require validation in a larger series with longer follow-up information.
CONCLUSIONS: FISH assay may be of help in the prognostic evaluation of atypical Spitzoid tumors. Diagnostic significance of BRAF(V600E) and H-RAS mutations in this setting remains unclear.
Copyright © 2010 American Academy of Dermatology, Inc. Published by Mosby, Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21496703     DOI: 10.1016/j.jaad.2010.05.043

Source DB:  PubMed          Journal:  J Am Acad Dermatol        ISSN: 0190-9622            Impact factor:   11.527


  7 in total

Review 1.  A diagnostic algorithm for atypical spitzoid tumors: guidelines for immunohistochemical and molecular assessment.

Authors:  Jeong Hee Cho-Vega
Journal:  Mod Pathol       Date:  2016-04-22       Impact factor: 7.842

2.  Role of miR-145 in chronic constriction injury in rats.

Authors:  Xiaolin Pang; Yuanzhang Tang; Dongya Zhang
Journal:  Exp Ther Med       Date:  2016-11-14       Impact factor: 2.447

3.  Comparison between melanoma gene expression score and fluorescence in situ hybridization for the classification of melanocytic lesions.

Authors:  Eugen C Minca; Rami N Al-Rohil; Min Wang; Paul W Harms; Jennifer S Ko; Angela M Collie; Ivanka Kovalyshyn; Victor G Prieto; Michael T Tetzlaff; Steven D Billings; Aleodor A Andea
Journal:  Mod Pathol       Date:  2016-05-13       Impact factor: 7.842

Review 4.  Review of diagnostic, prognostic, and predictive biomarkers in melanoma.

Authors:  Jacob S Ankeny; Brian Labadie; Jason Luke; Eddy Hsueh; Jane Messina; Jonathan S Zager
Journal:  Clin Exp Metastasis       Date:  2018-05-02       Impact factor: 5.150

Review 5.  Through the looking glass and what you find there: making sense of comparative genomic hybridization and fluorescence in situ hybridization for melanoma diagnosis.

Authors:  Jayson Miedema; Aleodor A Andea
Journal:  Mod Pathol       Date:  2020-02-17       Impact factor: 7.842

6.  A juvenile case of conjunctival atypical nevus.

Authors:  Cristina Colarossi; Mario Milazzo; Milena Paglierani; Daniela Massi; Lorenzo Memeo; Vincenzo Canzonieri
Journal:  Diagn Pathol       Date:  2013-04-22       Impact factor: 2.644

Review 7.  Time to reconsider Spitzoid neoplasms?

Authors:  Carmelo Urso
Journal:  Dermatol Pract Concept       Date:  2016-04-30
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.